Treatment of Uncomplicated Recurrent Urinary Tract Infection with Chinese Medicine Formula:A Randomized Controlled Trial
查看参考文献18篇
文摘
|
Objective:To evaluate Chinese medicine (CM) formula Bazheng Powder (八正散) as an alternative therapeutic option for female patients with recurrent urinary tract infection (RUTI).Methods:A randomized double-blinded trial was performed.Eligible female patients with RUTI were recruited from one hospital and two community health centers.By using a blocked randomization scheme,participants were randomized to receive a CM formula (10 herbs) and antibiotics placebo for 4 weeks,or antibiotics for 1 week followed by 3 weeks of placebo and CM formula placebo.Clinical cure rate and microbiological cure and recurrence after treatment were evaluated.Results:A total 122 eligible patients were enrolled,with 61 cases in each group.The clinical cure rate by the intent-to-treatment approach was 90.2% for the CM group and 82.0% for the antibiotics group (P>0.05).Bacteria were cleared from 88.5% (54/61) of patients in the CM group and 82.0% (50/61) in the antibiotics group.The recurrence rate in recovered patients at the 6-month follow-up was 9.1% (5/61) and 14.0 (7/61) in the CM and antibiotics groups,respectively (P>0.05).Conclusion:CM formula Bazheng Powder is a good alternative option for RUTI treatment.(Registration No.NCT01745328). |
来源
|
Chinese Journal of Integrative Medicine
,2019,25(1):16-22 【核心库】
|
DOI
|
10.1007/s11655-017-2960-4
|
关键词
|
Chinese medicine
;
recurrent urinary tract infection
;
randomized control trial
|
地址
|
1.
Department of Nephrology and Endocrinology,Wangjing Hospital,Chinese Academy of Chinese Medical Science, Beijing, 100102
2.
Institute of Integrative Medicine,Sun Yat-sen University, Guangzhou, 510275
3.
Institute of Disease Control and Prevention,Academy of Military Medical Sciences, Beijing, 100071
4.
College of Animal Science and Veterinary Medicine,Shenyang Agriculture University, Key Laboratory of Zoonosis of Liaoning Province, Shenyang, 110866
|
语种
|
英文 |
文献类型
|
研究性论文 |
ISSN
|
1672-0415 |
学科
|
中国医学 |
基金
|
Supported by Chinese Academy of Traditional Chinese Medicine Joint Innovation Research Project
;
Traditional Chinese Medicine Dominant Disease Clinical Research Project
;
Capital Featured Clinical Application and Promotion Project,China
|
文献收藏号
|
CSCD:6410946
|
参考文献 共
18
共1页
|
1.
Foxman B. The epidemiology of urinary tract infection.
Nature Rev Urol,2010,7:653-660
|
CSCD被引
20
次
|
|
|
|
2.
Hooton T M. Uncomplicated urinary tract infection.
N Engl J Med,2012,366:1028-1037
|
CSCD被引
8
次
|
|
|
|
3.
Beerepoot M A. Nonantibiotic prophylaxis for recurrent urinary tract infections: a systematic review and meta-analysis of randomized controlled trials.
J Uroly,2013,190:1981-1989
|
CSCD被引
7
次
|
|
|
|
4.
Stapleton A E. Randomized, placebocontrolled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection.
Clin Infect Dis,2011,52:1212-1217
|
CSCD被引
7
次
|
|
|
|
5.
Jiang W Y. Therapeutic wisdom in traditional Chinese medicine: a perspective from modern science.
Discov Med,2009,5:455-461
|
CSCD被引
1
次
|
|
|
|
6.
Han J N. Treatment of influenza: Chinese medicine vs. Western medicine.
J Thoracic Dis,2012,4:10-11
|
CSCD被引
1
次
|
|
|
|
7.
Wang C. Oseltamivir compared with the Chinese traditional therapy Maxingshigan-Yinqiaosan in the treatment of H1N1 influenza: a randomized trial.
Annal Intern Med,2011,155:217-225
|
CSCD被引
114
次
|
|
|
|
8.
Zhang N. Traditional Chinese medicine: an alternative treatment option for refractory recurrent urinary tract infections.
Clin Infect Dis,2013,56:1355
|
CSCD被引
3
次
|
|
|
|
9.
Gupta K. Patientinitiated treatment of uncomplicated recurrent urinary tract infections in young women.
Annal Intern Med,2001,135:9-16
|
CSCD被引
3
次
|
|
|
|
10.
Liu S W. Multi-drug resistant uropathogenic Escherichia coli and its treatment by Chinese medicine.
Chin J Integr Med,2016
|
CSCD被引
1
次
|
|
|
|
11.
Zheng X Y.
Guiding principles of clinical research on traditional Chinese drugs,2002
|
CSCD被引
1
次
|
|
|
|
12.
Liu S. Recurrent urinary tract infections caused by multidrug-resistant uropathogenic Escherichia coli: implications for diagnosis and treatment.
Eur Urol,2013,63:410-411
|
CSCD被引
1
次
|
|
|
|
13.
Leung W K. Treatment of diarrhea-predominant irritable bowel syndrome with traditional Chinese herbal medicine: a randomized placebocontrolled trial.
Am J Gastroenterol,2006,101:1574-1580
|
CSCD被引
8
次
|
|
|
|
14.
Hooton T M. Cefpodoxime vs ciprofloxacin for short-course treatment of acute uncomplicated cystitis: a randomized trial.
JAMA,2012,307:583-589
|
CSCD被引
2
次
|
|
|
|
15.
Jiang M. Traditional Chinese medicine Zheng in the era of evidence-based medicine: a literature analysis.
Evid Based Complement Alternat Med,2012,2012:409568
|
CSCD被引
9
次
|
|
|
|
16.
Lu N N. Gene Expression profiles underlying selective T-cell-mediated immunity activity of a Chinese medicine granule on mice infected with influenza virus H1N1.
Evid Based Complement Alternat Med,2014,2014:976364
|
CSCD被引
1
次
|
|
|
|
17.
Chen L. Modified Jiu Wei Qiang Huo decoction improves dysfunctional metabolomics in influenza A pneumonia-infected mice.
Biomed Chromatogr,2014,28:468-474
|
CSCD被引
2
次
|
|
|
|
18.
Mori R. Diagnosis and management of urinary tract infection in children: summary of NICE guidance.
BMJ,2007,335:395-397
|
CSCD被引
1
次
|
|
|
|
|